Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors

被引：10

作者：

Namoto, Kenji ^{[1
]}

Sirockin, Finton ^{[1
]}

Sellner, Holger ^{[1
]}

Wiesmann, Christian ^{[1
]}

Villard, Frederic ^{[1
]}

Moreau, Robert J. ^{[2
]}

Valeur, Eric ^{[1
,3
]}

Paulding, Stephanie C. ^{[1
]}

Schleeger, Simone ^{[1
]}

Schipp, Kathrin ^{[1
]}

Loup, Joachim ^{[1
]}

Andrews, Lori ^{[2
]}

Swale, Ryann ^{[2
]}

Robinson, Michael ^{[2
]}

Farady, Christopher J. ^{[1
]}

机构：

[1] Novartis Inst BioMed Res, Novartis Campus, CH-4002 Basel, Switzerland

[2] Novartis Inst BioMed Res, 5300 Chiron Way, Emeryville, CA 94608 USA

[3] AstraZeneca, IMED Biotech Unit, Med Chem Cardiovasc & Metab Dis, Gothenburg, Sweden

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2018年 / 28卷 / 05期

关键词：

Rhinovirus 3C protease; Protease inhibition; Covalent inhibitor; Macrocycle; Structure-based drug design; Solid phase synthesis; VITRO ANTIVIRAL ACTIVITY; BIOLOGICAL EVALUATION; DISCOVERY;

D O I：

10.1016/j.bmcl.2018.01.064

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The design and synthesis of macrocyclic inhibitors of human rhinovirus 3C protease is described. A macrocyclic linkage of the P1 and P3 residues, and the subsequent structure-based optimization of the macrocycle conformation and size led to the identification of a potent biochemical inhibitor 10 with sub-micromolar antiviral activity. (C) 2018 Elsevier Ltd. All rights reserved.

引用

页码：906 / 909

页数：4

共 50 条

[1] Structure-based design of irreversible human rhinovirus 3C protease inhibitors.
Dragovich, PS
Webber, SE
Babine, RE
Fuhrman, SA
Patick, AK
Matthews, DA
Reich, SH
Prins, TJ
Marakovits, JT
Littlefield, ES
Zhou, R
Tikhe, J
Ford, CE
Wallace, MB
Bleckman, TM
Meador, JW
Ferre, RA
Brown, EL
Binford, SL
DeLisle, DM
Worland, ST
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U863 - U863
[2] Structure-based design of irreversible, peptidomimetic human rhinovirus 3C protease inhibitors
Dragovich, PS
Webber, SE
Fuhrman, SA
Patick, AK
Matthews, DA
Prins, TJ
Zhou, R
Marakovits, JT
Ford, CE
Meador, JW
Ferre, RA
Worland, ST
MEDICINAL CHEMISTRY INTO THE MILLENNIUM, 2001, (264): : 223 - 232
[3] Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation
Reich, SH
Johnson, T
Wallace, MB
Kephart, SE
Fuhrman, SA
Worland, ST
Matthews, DA
Hendrickson, TF
Chan, F
Meador, J
Ferre, RA
Brown, EL
DeLisle, DM
Patick, AK
Binford, SL
Ford, CE
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (09) : 1670 - 1683
[4] Structure-based design of irreversible peptidyl and peptidomimetic human rhinovirus 3C protease inhibitors.
Dragovich, PS
Webber, SE
Fuhrman, SA
Patick, AK
Matthews, DA
Lee, CA
Tuntland, T
Prins, TJ
Marakovits, JT
Zhou, R
Tikhe, J
Ford, CE
Meador, JW
Harr, JEV
Kosa, MB
Ferre, RA
Brown, EL
Binford, SL
DeLisle, DM
Worland, ST
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1233 - U1233
[5] Structure-based design of ketone-containing human rhinovirus 3C protease inhibitors.
Dragovich, PS
Zhou, R
Webber, SE
Prins, TJ
Kwok, AK
Okano, K
Fuhrman, SA
Zalman, LS
Maldonado, FG
Brown, EL
Patick, AK
Matthews, DA
Ford, CE
Brothers, MA
Meadow, JW
Ferre, RA
Binford, SL
Worland, ST
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U3 - U3
[6] Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors
Dragovich, PS
Zhou, R
Webber, SE
Prins, TJ
Kwok, AK
Okano, K
Fuhrman, SA
Zalman, LS
Maldonado, FC
Brown, EL
Meador, JW
Patick, AK
Ford, CE
Brothers, MA
Binford, SL
Matthews, DA
Ferre, RA
Worland, ST
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (01) : 45 - 48
[7] Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors
Webber, SE
Marakovits, JT
Dragovich, PS
Prins, TJ
Zhou, R
Fuhrman, SA
Patick, AK
Matthews, DA
Lee, CA
Srinivasan, B
Moran, T
Ford, CE
Brothers, MA
Harr, JEV
Meador, JW
Ferre, RA
Worland, ST
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) : 2683 - 2686
[8] Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease
Webber, SE
Tikhe, J
Worland, ST
Fuhrman, SA
Hendrickson, TF
Matthews, DA
Love, RA
Patick, AK
Meador, JW
Ferre, RA
Brown, EL
DeLisle, DM
Ford, CE
Binford, SL
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (26) : 5072 - 5082
[9] Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease
Johnson, TO
Hua, Y
Luu, HT
Brown, EL
Chan, F
Chu, SS
Dragovich, PS
Eastman, BW
Ferre, RA
Fuhrman, SA
Hendrickson, TF
Maldonado, FC
Matthews, DA
Meador, JW
Patick, AK
Reich, SH
Skalitzky, DJ
Worland, ST
Yang, M
Zalman, LS
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) : 2016 - 2023
[10] Design, synthesis, and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease
Venkatraman, S
Kong, JS
Nimkar, S
Wang, QM
Aubé, J
Hanzlik, RP
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (04) : 577 - 580

← 1 2 3 4 5 →